Qin-qin Wang
Nanchang, 330004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cells.
Journal: International immunopharmacology
Published: January 13, 2026
A multi-omics approach to decipher the protective mechanism of Myristica fragrans against acute lung injury.
Journal: Journal of ethnopharmacology
Published: December 01, 2025
Dihydrotanshinone Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Targeting NEK7 to Inhibit NLRP3 Inflammasome Activation.
Journal: Phytotherapy research : PTR
Published: August 12, 2025
Pedunculoside targets P2X7R to protect against myocarditis by regulating the NLRP3/PIP2/MAPK signaling pathway.
Journal: Frontiers in pharmacology
Published: March 07, 2025
Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways.
Journal: Chinese medicine
Published: February 23, 2025
Correction: Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways.
Journal: Chinese medicine
Published: August 28, 2024
Oleuropein alleviates myocardial ischemia-reperfusion injury by suppressing oxidative stress and excessive autophagy via TLR4/MAPK signaling pathway.
Journal: Chinese medicine
Published: January 04, 2024
Hederasaponin C inhibits LPS-induced acute kidney injury in mice by targeting TLR4 and regulating the PIP2/NF-κB/NLRP3 signaling pathway.
Journal: Phytotherapy research : PTR
Published: June 24, 2023
Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways.
Journal: Chinese medicine
Published: January 03, 2022
Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway.
Journal: Frontiers in immunology
Published: December 31, 2021
Cryptotanshinone Induces Necroptosis Through Ca2+ Release and ROS Production in vitro and in vivo.
Journal: Current molecular pharmacology
Published: August 21, 2021
Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis.
Journal: Pharmacological research
Published: April 20, 2021
Last Updated: 09/26/2026